REPRODERM
Where Struture Meets Natural Form
Verified biocompatibility
High preservation of ECM for tissue regeneration
Excellent suture strength
Elastic and flexible properties
more stable and predictable shape
Reproderm is an acellular dermal matrix (ADM) xenograft developed for use in rhinoplasty, utilizing EER (Excellent Extracellular Matrix Retention) Technology. This advanced, patented decellularization process effectively removes cellular and immune components while preserving the native collagen structure and extracellular matrix (ECM), ensuring both biocompatibility and regenerative potential.
Multiple
placement
Firm and
solid to touch
Hydrated
ready to use
EER* Technology
Regeneration of new tissues with various ecm
Maintains up to
98%
of its volume
-
Proven biocompatibility and safety, verified through endotoxin, cytotoxicity, and DNA quantification tests (DNA < 50 ng/mg), in accordance with international standards.
-
High tissue integration, demonstrated by cell infiltration and repopulation within one month after implantation.
-
Active tissue regeneration, with progressive formation and rearrangement of various ECM components (collagen, muscle layer, cytoplasm, nucleus) observed at 1, 3, and 6 months post-implantation.
-
Superior volume retention, maintaining up to 98% of its original volume and up to 1.9 times greater volume preservation compared with other allograft and xenograft materials.
-
Mechanical properties similar to allografts, providing appropriate flexibility and handling characteristics for surgical use.